The complex of a designer antibiotic with a model aminoacyl site of the 30S ribosomal subunit revealed by X-ray crystallography.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American Chemical Society

• Publication date

  2003-02-28

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JA029736HPMID 12643685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The bacterial ribosome, a promising focus for structure-based drug design.

  2002cited by this paper
• Design of novel antibiotics that bind to the ribosomal acyltransfer site.

  2002cited by this paper
• Ribosome structure and the mechanism of translation.

  2002cited by this paper
• Substrate promiscuity of an aminoglycoside antibiotic resistance enzyme via target mimicry.

  2002cited by this paper
• Recognition of Cognate Transfer RNA by the 30S Ribosomal Subunit

  2001cited by this paper
• Feynman's Path-Integral Approach for Intense-Laser-Atom Interactions

  2001cited by this paper
• Crystal structure of paromomycin docked into the eubacterial ribosomal decoding A site.

  2001cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Aminoglycoside antibiotics. Structures, functions, and resistance.

  1998cited by this paper
• [21] Data collection strategy.

  1997cited by this paper

• Molecular basis of the pleiotropic effects by the antibiotic amikacin on the ribosome

  2023cites this paper
• Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

  2018cites this paper
• Drug-target interactions that involve the replacement or displacement of magnesium ions.

  2017cites this paper
• Amikacin: Uses, Resistance, and Prospects for Inhibition

  2017cites this paper
• Progress of Chiral Schiff Bases with C1 Symmetry in Metal-Catalyzed Asymmetric Reactions.

  2016cites this paper
• Synthesis and Antiribosomal Activities of 4'-O-, 6'-O-, 4″-O-, 4',6'-O- and 4″,6″-O-Derivatives in the Kanamycin Series Indicate Differing Target Selectivity Patterns between the 4,5- and 4,6-Series of Disubstituted 2-Deoxystreptamine Aminoglycoside Antibiotics.

  2015cites this paper
• Orthogonal High-Throughput Screens Antibacterial Activities Using Two Characterization of Ribosomal Binding and

  2014cites this paper
• Characterization of Ribosomal Binding and 1 Antibacterial Activities Using Two Orthogonal High 2 Throughput Capable Screens 3 4

  2013cites this paper
• Characterization of Ribosomal Binding and Antibacterial Activities Using Two Orthogonal High-Throughput Screens

  2013cites this paper
• Aminoglycoside Antibiotics: Structural Decoding of Inhibitors Targeting the Ribosomal Decoding A Site

  2013cites this paper
• Understanding and overcoming aminoglycoside resistance caused by N-6'-acetyltransferase.

  2012cites this paper
• Quantum kernel applications in medicinal chemistry.

  2012cites this paper
• Antibiotics that target protein synthesis

  2011cites this paper
• Chemical and structural biology of nucleic acids and protein-nucleic acid complexes for novel drug discovery

  2011cites this paper
• Isolation And Analysis Of Peptides Binding To Helix 69 Of E. Coli 23 S Rrna From M13 Phage Display

  2011cites this paper
• Method Development And Applications To Screening And Characterization Of Rrna-Targeting Small Molecules

  2011cites this paper
• DNA and RNA Binding Small Molecules

  2011cites this paper
• Kernel energy method: Drug–target interaction energies for drug design

  2010cites this paper
• Antibiotics Targeting the Ribosome: Structure-Based Design and the Nobel Prize

  2010cites this paper
• Tetracycline, Aminoglycoside, Macrolide, and Miscellaneous Antibiotics

  2010cites this paper
• The Future of Aminoglycosides: The End or Renaissance?

  2010cites this paper
• Quantum Kernels and Quantum Crystallography: Applications in Biochemistry

  2010cites this paper
• Antibiotic Resistance by Enzyme Inactivation: From Mechanisms to Solutions

  2010cites this paper
• Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila*

  2010cites this paper
• Molecular recognition of RNA: challenges for modelling interactions and plasticity

  2009cites this paper
• Aminoglycosides: Molecular Insights on the Recognition of RNA and Aminoglycoside Mimics

  2009cites this paper
• Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations.

  2009cites this paper
• The use of ribosomal crystal structures in antibiotic drug design.

  2009cites this paper
• [Novel molecular mechanisms of antibiotic resistance found in clinically isolated pathogenic bacteria].

  2009cites this paper
• RNA’s coming of age as a drug target

  2009cites this paper
• Asymmetric desymmetrization of 4,5-epoxycyclohex-1-ene by enantioselective allylic oxidation.

  2009cites this paper
• Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.

  2008cites this paper
• Surprising alteration of antibacterial activity of 5"-modified neomycin against resistant bacteria.

  2008cites this paper
• Targeting RNA with small molecules.

  2008cites this paper
• Combined Chemical‐Enzymatic Assembly of Aminoglycoside Derivatives with N‐1‐AHB Side Chain

  2008cites this paper
• Drug target interaction energies by the kernel energy method in aminoglycoside drugs and ribosomal A site RNA targets

  2007cites this paper
• Synthesis and antibacterial activity of pyranmycin derivatives with N-1 and O-6 modifications.

  2007cites this paper
• Novel Plasmid-Mediated 16S rRNA m1A1408 Methyltransferase, NpmA, Found in a Clinically Isolated Escherichia coli Strain Resistant to Structurally Diverse Aminoglycosides

  2007cites this paper
• Potential New Antibiotic Sites in the Ribosome Revealed by Deleterious Mutations in RNA of the Large Ribosomal Subunit*

  2007cites this paper
• Modifications of aminoglycoside antibiotics targeting RNA

  2007cites this paper
• Back to the future: the ribosome as an antibiotic target.

  2007cites this paper
• Multi-targeting by monotherapeutic antibacterials

  2007cites this paper
• Structure-based design, synthesis, and A-site rRNA cocrystal complexes of functionally novel aminoglycoside antibiotics: C2" ether analogues of paromomycin.

  2007cites this paper
• Multi-targeting by monotherapeutic antibacterials

  2007cites this paper
• The use of aminoglycoside derivatives to study the mechanism of aminoglycoside 6'-N-acetyltransferase and the role of 6'-NH2 in antibacterial activity.

  2007cites this paper
• Mechanisms of Aminoglycoside Antibiotic Resistance

  2007cites this paper
• 7.21 – Aminoglycosides Antibiotics

  2007cites this paper
• Crystal Structure of the Bacterial Ribosomal Decoding Site Complexed with a Synthetic Doubly Functionalized Paromomycin Derivative: a New Specific Binding Mode to an A‐Minor Motif Enhances in vitro Antibacterial Activity

  2007cites this paper
• Aminoglycoside antibiotics: old drugs and new therapeutic approaches

  2007cites this paper
• Structure-Based Design, Synthesis, and A-Site rRNA Cocrystal Complexes of Functionally Novel Aminoglycoside Antibiotics: C2'' Ether Analogues of Paromomycin

  2007cites this paper
• A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns.

  2006cites this paper
• A-site model RNAs.

  2006cites this paper
• bioch of an aminoglycoside / A-site RNA complex : conformational and hydration patterns

  2006cites this paper
• Conformationally Constrained Aminoglycosides: Ribosomal Binding Probes and Potential Antibiotics

  2006cites this paper
• Towards the discovery of drug-like RNA ligands?

  2006cites this paper
• Switchable RNA Motifs As Drug Targets

  2006cites this paper
• Structure-based drug design meets the ribosome.

  2006cites this paper
• Crystal structure of the bacterial ribosomal decoding site complexed with amikacin containing the γ-amino-α-hydroxybutyryl (haba) group

  2006cites this paper
• Crystal structure of the bacterial ribosomal decoding site complexed with amikacin containing the gamma-amino-alpha-hydroxybutyryl (haba) group.

  2006cites this paper
• Synthesis and antibacterial activity of novel neamine derivatives.

  2006cites this paper
• Interactions of designer antibiotics and the bacterial ribosomal aminoacyl-tRNA site.

  2006cites this paper
• Modele + A-site model RNAs

  2006cites this paper
• RNA as a target for small-molecule therapeutics

  2005cites this paper
• Improving on nature: antibiotics that target the ribosome.

  2005cites this paper
• Drugs targeting the ribosome.

  2005cites this paper
• The synthesis and 16S A-site rRNA recognition of carbohydrate-free aminoglycosides.

  2005cites this paper
• Aminoglycoside‐Hybrid Ligands Targeting the Ribosomal Decoding Site

  2005cites this paper
• Aminoglycoside Kinases and Antibiotic Resistance

  2005cites this paper
• Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding

  2005cites this paper
• Rational design of azepane-glycoside antibiotics targeting the bacterial ribosome.

  2004cites this paper
• Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.

  2004cites this paper
• A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site.

  2004cites this paper
• Three-dimensional motifs from the SCOR, structural classification of RNA database: extruded strands, base triples, tetraloops and U-turns.

  2004cites this paper
• Antibacterial aminoglycosides with a modified mode of binding to the ribosomal-RNA decoding site.

  2004cites this paper
• Efficient preparation of a 1,3-diazidocyclitol as a versatile 2-deoxystreptamine precursor.

  2004cites this paper
• Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots".

  2004cites this paper
• Aminoglycoside array for the high-throughput analysis of small molecule–RNA interactions

  2004cites this paper
• Deoxystreptamine dimers bind to RNA hairpin loops.

  2004cites this paper
• Synthesis of a protected enantiomerically pure 2-deoxystreptamine derivative from D-allylglycine

  2004cites this paper
• Preferred RNA binding sites for a threading intercalator revealed by in vitro evolution.

  2003cites this paper
• Mechanisms of resistance to antibiotics.

  2003cites this paper